PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,465 | -13.0% | 17,405 | 0.0% | 0.00% | – |
| Q1 2023 | $44,209 | +35.8% | 17,405 | 0.0% | 0.00% | – |
| Q4 2022 | $32,547 | -27.7% | 17,405 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +32.4% | 17,405 | 0.0% | 0.00% | – |
| Q2 2022 | $34,000 | -91.2% | 17,405 | -86.6% | 0.00% | – |
| Q1 2022 | $386,000 | -29.9% | 129,672 | +5.7% | 0.00% | – |
| Q4 2021 | $551,000 | -2.7% | 122,653 | +5.4% | 0.00% | – |
| Q3 2021 | $566,000 | -72.6% | 116,342 | -61.6% | 0.00% | -100.0% |
| Q2 2021 | $2,065,000 | +6.5% | 302,670 | +10.2% | 0.00% | 0.0% |
| Q1 2021 | $1,939,000 | +14.1% | 274,540 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $1,700,000 | +17.5% | 271,478 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $1,447,000 | +5.9% | 267,332 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $1,366,000 | +92.1% | 261,654 | +16.0% | 0.00% | – |
| Q1 2020 | $711,000 | -12.3% | 225,597 | +12.2% | 0.00% | – |
| Q4 2019 | $811,000 | -2.8% | 201,028 | +4.2% | 0.00% | – |
| Q3 2019 | $834,000 | +25.4% | 192,883 | +15.9% | 0.00% | – |
| Q2 2019 | $665,000 | -16.9% | 166,448 | +11.6% | 0.00% | -100.0% |
| Q1 2019 | $800,000 | -1.1% | 149,192 | -5.3% | 0.00% | 0.0% |
| Q4 2018 | $809,000 | -47.7% | 157,535 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $1,548,000 | +8.3% | 159,527 | +13.8% | 0.00% | 0.0% |
| Q2 2018 | $1,430,000 | -14.6% | 140,130 | +8.8% | 0.00% | 0.0% |
| Q1 2018 | $1,674,000 | +1.2% | 128,746 | +39.4% | 0.00% | 0.0% |
| Q4 2017 | $1,654,000 | -19.8% | 92,366 | +12.4% | 0.00% | -50.0% |
| Q3 2017 | $2,063,000 | +133.6% | 82,164 | +124.4% | 0.00% | +100.0% |
| Q2 2017 | $883,000 | +82.4% | 36,608 | +45.8% | 0.00% | – |
| Q1 2017 | $484,000 | +25.1% | 25,108 | 0.0% | 0.00% | – |
| Q4 2016 | $387,000 | +18.3% | 25,108 | 0.0% | 0.00% | – |
| Q3 2016 | $327,000 | -6.6% | 25,108 | 0.0% | 0.00% | – |
| Q2 2016 | $350,000 | +32.1% | 25,108 | +44.2% | 0.00% | – |
| Q1 2016 | $265,000 | -19.9% | 17,408 | 0.0% | 0.00% | – |
| Q4 2015 | $331,000 | 0.0% | 17,408 | 0.0% | 0.00% | – |
| Q3 2015 | $331,000 | -26.3% | 17,408 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $449,000 | – | 17,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |